| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/21/2009 | US7563806 Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament |
| 07/21/2009 | US7563805 Tri-, tetra-substituted-3-aminopyrrolidine derivative |
| 07/21/2009 | US7563803 M3 muscarinic acetylcholine receptor antagonists |
| 07/21/2009 | US7563801 With lactose, microcrystalline cellulose, croscarmellose sodium, pregelatinized starch, and magnesium stearate; storage stability; capsules; anticancer agents |
| 07/21/2009 | US7563800 Substituted pyrazolo[3,4-D]pyrimidines as p38 map kinase inhibitors |
| 07/21/2009 | US7563799 preferential enzyme inhibitors comprising fused pyrazolo derivatives, used for treating arthritis, Crohns disease, irritable bowel syndrome, adult respiratory distress syndrome, or chronic obstructive pulmonary disease |
| 07/21/2009 | US7563798 3-(1-Methyl-pyrazol-4-yl-),4-Piperidino,7-((3-Methyl-isothiazol-5-yl)-pyrazolo(1,5-a) pyrimidine; cyclin dependent kinase inhibitors; anticarcinogenic agents; antiinflammatory agents; antiarthritic agents; viricides; neurodegenerative diseases; Alzheimer's disease;cardiovascular diseases; fungicides |
| 07/21/2009 | US7563797 Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands |
| 07/21/2009 | US7563796 8-(4-Tert-butylphenyl)-8-phenyl-2,3,4,8-tetrahydroimidazol[1, 5-a]pyrimidin-6-amine; Alzheimer's disease; treating beta-amyloid deposits and neurofibrillary tangles; Sown syndrome; dementia; neurodenerative diseases; Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-type; cognition activators |
| 07/21/2009 | US7563795 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
| 07/21/2009 | US7563794 Ziprasidone free from colored impurities and a process for its preparation |
| 07/21/2009 | US7563793 Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents |
| 07/21/2009 | US7563792 Biguanide and dihydrotriazine derivatives |
| 07/21/2009 | US7563791 6-(Methoxymethyl)-5-(4-nitrophenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine; antiproliferative agents; angiogenesis inhibition; anticarcinogenic agents; breast cancer; colon cancer; antitumor agents |
| 07/21/2009 | US7563790 Pyridazine derivatives |
| 07/21/2009 | US7563789 1-Adamantyl chalcones for the treatment of proliferative disorders |
| 07/21/2009 | US7563788 3-[2-(3-Ethyl-ureido)-7-pyridin-3-yl-imidazo[1,2-a]pyridin-5-yl]-[1,2,4]oxadiazole-5-carboxylic acid methylamide; antibiotic resistance; grampositive, gramnegative, anaerobic bacteria; otitis; sinusitis, pharyngitis/tonsilitis, bronchitis, urinary tract infections, skin infections, pneumonia, septicemia |
| 07/21/2009 | US7563787 Substituted pyrazole compounds |
| 07/21/2009 | US7563786 Substituted thiophenecarboxamides, their preparation and their use as medicaments |
| 07/21/2009 | US7563785 Quetiapine analogs and methods of use thereof |
| 07/21/2009 | US7563784 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 07/21/2009 | US7563783 High binding to vitamin D receptors; intestinal calcium transport activity; psoriasis; leukemia; anticarcinogenic agents; multiple sclerosis; lupus; antidiabetic agents; host versus graft/organ reaction; antiinflammatory agents; rheumatoid arthritis; asthma; inflammatory bowel disease; skin/bone disorder |
| 07/21/2009 | US7563782 Optically active stereoisomer of efonidipine analogs; R-configuration of the 4-position on dihydropyridine ring; kidney insufficiency; hypercardia; congestive heart failure; cardiomyopathy; arterial sclerosis; antifibrillatory/antiarrhythmia agents; cardiovascular disorders; antiedemic/antiinflammatory |
| 07/21/2009 | US7563781 Such as 1-dimethylamino-3-[4-(3-indan-5-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-ylamino)-phenoxy]-propan-2-ol; serine-tyrosine and tyrosine kinase inhibitors; cancer, metastasis |
| 07/21/2009 | US7563780 Heparin prodrugs and drug delivery stents formed therefrom |
| 07/21/2009 | US7563779 Side effect reduction; synergistic mixtures |
| 07/21/2009 | US7563778 Antisense oligonucleotide preparation method |
| 07/21/2009 | US7563777 Method to induce neovascular formation and tissue regeneration |
| 07/21/2009 | US7563776 First sequence of human low affinity nerve growth factor receptor or a polynucleotide coding for it and a second sequence of a mutant hiv nef gene or a polynucleotide coding for it |
| 07/21/2009 | US7563775 Insulin-responsive DNA binding protein-1 and methods to regulate insulin-responsive genes |
| 07/21/2009 | US7563774 Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
| 07/21/2009 | US7563773 praziquantel and ivermectin dissolved in glycerol formal, with thickener for improved bioavailability |
| 07/21/2009 | US7563768 Administering hepatocyte growth factor to suppress inflammation |
| 07/21/2009 | US7563765 Histidine-rich glycoprotein |
| 07/21/2009 | US7563763 FSH and FSH variant formulations, products and methods |
| 07/21/2009 | US7563762 Composition and process for stabilizing of biomolecules |
| 07/21/2009 | US7563617 Hybrid adenovirus/adeno-associated virus vectors and methods of use thereof |
| 07/21/2009 | US7563586 Tetrodotoxin resistant membrane protein for use in pain management |
| 07/21/2009 | US7563565 balancing and maintaining Cortisol levels by identifying hormonal needs for a human, testing to ascertain the baseline hormone levels, inserting the values of baseline hormone level for each hormone into a hormone tree, balancing the hormones to a normal level, adjusting the levels for symptoms and sex |
| 07/21/2009 | US7563467 Use of an Opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells |
| 07/21/2009 | US7563461 Zinc salt compositions for the prevention of dermal and mucosal irritation |
| 07/21/2009 | US7563460 coated dosage forms of capsule, a tablet contains ethylenediamine tetraacetic acid, and on surface cathode and anode protruding from the surface thereof; creating a galvanic current upon contact of the dosage, release the acid to dissolve the stone; controlled release |
| 07/21/2009 | US7563458 Nutritional compositions for nutritional management of patients with liver disease |
| 07/21/2009 | US7563442 Antibodies to CD40 and methods of treating cancer and enhancing immune responses |
| 07/21/2009 | US7563434 Consumer product comprising a natural preservative system and a method for making the same |
| 07/21/2009 | US7563278 Drug-eluting intravascular prostheses and methods of use |
| 07/21/2009 | CA2514750C Methods and compositions utilizing astaxanthin |
| 07/21/2009 | CA2495943C Indoles having anti-diabetic activity |
| 07/21/2009 | CA2478393C 1-allyl ergot alkaloid derivatives, methods for their production and their use for migraine prevention and treatment |
| 07/21/2009 | CA2470809C 6-amino-morphinan derivatives, method of manufacturing them and their application |
| 07/21/2009 | CA2409845C Active substance combination containing a compound with an opioid effect and at least one further compound of formula i |
| 07/21/2009 | CA2408848C Rapidly disintegrating solid oral dosage form |
| 07/21/2009 | CA2404548C 2-alkylidene-19-nor-vitamin d compounds and their therapeutic uses |
| 07/21/2009 | CA2387486C Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 07/21/2009 | CA2386423C Pharmaceutical compositions containing copper, salicylic acid and vitamines c |
| 07/21/2009 | CA2386215C Method for treatment of chronic venous insufficiencies using an extract of red vine leaves |
| 07/21/2009 | CA2382098C Sustained-release, oral pharmaceutical forms of administration |
| 07/21/2009 | CA2380481C Process for preparing a charcoal-gm1 complex |
| 07/21/2009 | CA2379972C Prodrug of an ice inhibitor |
| 07/21/2009 | CA2367921C Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents |
| 07/21/2009 | CA2348988C Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor |
| 07/21/2009 | CA2288789C Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands |
| 07/21/2009 | CA2261690C Antiprotozoal composition |
| 07/21/2009 | CA2253348C Regulating metabolism by modifying the level of trehalose-6-phosphate |
| 07/21/2009 | CA2201310C Antineoplastic cocoa extracts and methods for making and using the same |
| 07/18/2009 | CA2650135A1 Process for obtaining dried plant material |
| 07/18/2009 | CA2649978A1 Lubricious, non-tacky personal lubricant |
| 07/16/2009 | WO2009089547A1 Isothiazole-pyridine derivatives as modulators of hif (hypoxia inducible factor) activity |
| 07/16/2009 | WO2009089545A1 Synthetic triterpenoids and methods of use in the treatment of disease |
| 07/16/2009 | WO2009089537A2 Anti-cancer compounds |
| 07/16/2009 | WO2009089508A1 Activators of executioner procaspases 3, 6 and 7 |
| 07/16/2009 | WO2009089494A2 Pharmaceutical compositions |
| 07/16/2009 | WO2009089493A2 Nitrate amino acid chelates |
| 07/16/2009 | WO2009089482A1 (1-azinone) -substituted pyridoindoles as mch antagonists |
| 07/16/2009 | WO2009089462A1 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors |
| 07/16/2009 | WO2009089459A1 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 07/16/2009 | WO2009089454A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 07/16/2009 | WO2009089453A1 Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor |
| 07/16/2009 | WO2009089448A1 Therapeutic disulfide compounds for treating pain and diabetes |
| 07/16/2009 | WO2009089442A1 Use of cranberry derivative and d-mannose composition for preventing, controlling and ameliorating urinary tract infections |
| 07/16/2009 | WO2009089422A2 Inhalation drug products, systems and uses |
| 07/16/2009 | WO2009089383A2 Inhibitors of carbonic anhydrase ix |
| 07/16/2009 | WO2009089366A2 Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with metabolic modulators |
| 07/16/2009 | WO2009089365A2 Therapeutic formulations based on asiatic acid and selected salts thereof |
| 07/16/2009 | WO2009089361A2 Systems methods and formulation for topically treating nail fungal infection and nail psoriasis |
| 07/16/2009 | WO2009089359A1 Pyrazolopyridines as kinase inhibitors |
| 07/16/2009 | WO2009089352A1 Pyrrolopyridines as kinase inhibitors |
| 07/16/2009 | WO2009089338A2 Method and compositions for administering resveratrol and pterostilbene |
| 07/16/2009 | WO2009089312A1 (e)-n-{3- [1-(8-fluoro-11h-10-oxa-1-aza-dibenzo [a,d] cycl0hepten-5ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid |
| 07/16/2009 | WO2009089284A2 Substituted 2-aminotetralin derivatives as selective alpha 2b agonist |
| 07/16/2009 | WO2009089277A2 Rel inhibitors and methods of use thereof |
| 07/16/2009 | WO2009089260A2 Combination of anti-ctla4 antibody with tubulin modulating agents for the treatment of proliferative diseases |
| 07/16/2009 | WO2009089237A1 Compositions containing o-sulfate and o-phosphate containing aryl sulfonamide derivatives useful as beta-amyloid inhibitors |
| 07/16/2009 | WO2009089235A1 Preparation of sulfamide derivatives |
| 07/16/2009 | WO2009089234A2 Substituted dibenzhydrylpiperazines |
| 07/16/2009 | WO2009089224A1 (HET) ARYL-p-QUINONE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES |
| 07/16/2009 | WO2009089210A1 Preparation of sulfamide derivatives |
| 07/16/2009 | WO2009089192A1 2-phenyl phenoxyacetic acids useful for treating inflammatory disorders |
| 07/16/2009 | WO2009089147A2 Methods and compositions for the treatment of cancers and pathogenic infections |
| 07/16/2009 | WO2009089144A1 Ketone bodies and ketone body esters as blood lipid lowering agents |